أعاد Firstline نشر هذا
DoseMe is pleased to welcome Richard Malone, Pharm.D., MHA, as Vice President, Clinical & Science. His appointment comes at an exciting moment as DoseMe continues integrating capabilities from Firstline, bringing evidence-based antimicrobial selection together with Bayesian model-informed precision dosing in a unified clinical workflow. “Richard’s unique combination of frontline clinical expertise, operational leadership, and healthcare technology experience strengthens our ability to deliver scientifically rigorous, clinically practical precision dosing solutions,” said CEO John Hardesky. The combined platform enables health systems to align antimicrobial stewardship strategy, prescribing guidance, and individualized dosing optimization to improve patient outcomes while helping reduce resistance risk. Richard brings more than 30 years of leadership experience across hospital pharmacy operations, healthcare technology, investigational drug services, and executive leadership. Read the full release here: https://lnkd.in/eNRNb8MM Please join us in welcoming Rick to the DoseMe team as we continue advancing precision dosing and antimicrobial stewardship for health systems worldwide. #PrecisionDosing #AntimicrobialStewardship #HealthcareInnovation #PharmacyLeadership